Walvax沃森生物

CN
EN

Help Everyone Live a Healthy Life

Walrinvax™ Pre-Qualified by WHOㅤㅤㅤ

ㅤㅤㅤ

Walvax Publishes Immunogenicity and Safety Data

from Phase 3 Clinical Study of PCV13

in Frontiers in Microbiology

 

ㅤㅤㅤ

ㅤㅤㅤ

ㅤㅤㅤ

Advanced, Modular and Digital mRNA Workshop

Investors

Walvax aims to become a high-quality, cost-effective and sustainable global vaccine producer. 

Learn More

R&D

We have abundant blockbuster pipelines in clinical stage, and keep investing a significant amount of revenue into R&D.  

Learn More

Products

We have successfully developed and licensed 8 vaccines and protected hundreds of millions of people from diseases. 

Learn More

About Walvax

Founded in 2001, Walvax is mainly engaged in research and development, manufacturing and distribution of safe and efficacious vaccines. With the purpose of “Help everyone live a healthy life”, Walvax aims to be a leader in public health, sustainably providing high-quality and innovative products to protect against the world’s deadliest diseases.

Learn More
Performance Innovation Marketing
571.4
USD571.4 million revenue in 2023
TOP 10
Top 10 manufacturers by value in 2022 (excluding COVID-19 vaccines) ——WHO's Global Vaccine Market Report 2022
75
75 authorized invention patents at home and abroad
10+
10+ patents application in progress
220+
220+ cities covered in China
20
Products exported to 20 countries
23
23 countries registration in progress

Join Us

You’ll partner with colleagues of diverse backgrounds and abilities. 

Learn More

Responsibility

We are focused on the areas of greatest need.

Learn More